CRDL Cardiol Therapeutics Inc.

0.8738USD1.250 CAD · TSX-8.09%Mkt Cap: 111.57M USDP/E: —

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx,…

Institutional holders12 on file

Key Statistics

Company
Market Cap111.57M USD
Enterprise Value101.89M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-23.64M USD
Revenue/Share—
Last Price0.8738 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees18
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA14161Y2006
Valuation
P/E (Trailing)—
P/E (Forward)-3.80
PEG—
EV/EBITDA-4.07
EV/Revenue—
P/S—
P/B7.02
EPS (TTM)-0.24 USD
EPS (Forward)-0.23 USD
52W Range
0.85631% of range2.258
52W High2.258 USD
52W Low0.8563 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-189.17%
ROA-143.18%
ROIC—
ROCE-191.02%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.68M USD
CapEx (TTM)17.12K USD
FCF Margin—
FCF Yield-9.70%
Net Debt-18.16M USD
Net Debt/EBITDA0.72
Net Debt/FCF—
Balance Sheet
Debt/Equity0.01
Current Ratio5.55
Quick Ratio5.01
Book Value/Sh0.12 USD
Cash/Share0.16 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.893 USD
Upside (mean)+460.0%
Target Range4.893 USD – 4.893 USD
# Analysts1
Ownership
Shares Out.127.69M
Float91.98M
Insiders2.22%
Institutions26.91%
Short Interest
Short Ratio3.3d
Short % Float0.56%
Short % Out.0.54%
Shares Short659.17K
Short (prev mo.)609.77K
Technical
SMA 501.351 (-35.3%)
SMA 2001.270 (-31.2%)
Beta0.66
S&P 52W Chg12.00%
Avg Vol (30d)116.47K
Avg Vol (10d)76.60K
Technical Indicators
RSI (14)26.6
MACD-0.1376
MACD Signal-0.1456
MACD Hist.+0.0080
BB Upper1.197 USD
BB Middle1.036 USD
BB Lower0.8742 USD
BB Width31.17%
ATR (14)0.0666 USD
Vol Ratio (20d)1.32x

About Cardiol Therapeutics (TSE: CRDL)

›

Cardiol Therapeutics (TSE: CRDL) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 18 employees.

The shares were at 1.250 CAD on 19 November 2026, down 13.2% over 52 weeks. Its 52-week range is 1.225 CAD to 3.230 CAD: the price is 61.3% below the high and 2.0% above the low.

Its market capitalisation is 159.61M CAD.

Cardiol Therapeutics reports return on equity of -189.2% and an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 25.97M CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. The next earnings report is expected on 31 March 2027.